Northwestern Mutual Wealth Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5K Sell
298
-213
-42% -$6.29K ﹤0.01% 3102
2026
Q1
$14.2K Buy
+511
New +$13.1K ﹤0.01% 2935
2025
Q3
Sell
-10
Closed -$113 4014
2025
Q2
$113 Buy
+10
New +$108 ﹤0.01% 3546

Other funds holding ROIV

Northwestern Mutual Wealth Management's ROIV Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Roivant Sciences (ROIV) stake by 42% in Q2 2026, selling an estimated $6.29K and leaving 298 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

Northwestern Mutual Wealth Management first reported a position in ROIV in Q2 2025 and has held it in 3 quarters since. The position peaked at $14.2K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Northwestern Mutual Wealth Management held 298 shares of Roivant Sciences worth $10.5K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 213 Roivant Sciences shares in Q2 2026, an estimated $6.29K.
  • Roivant Sciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3102 holding.
  • Northwestern Mutual Wealth Management first reported a position in Roivant Sciences in Q2 2025 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's Roivant Sciences position peaked at $14.2K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.